Amoéba S.A.
ALMIB.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.91M
Close$
Share Statistics
| Market cap | $22.91 Million |
|---|---|
| Enterprise Value | $31.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.12 |
| Beta | 0.21 |
| Outstanding Shares | 77,853,000 |
Return
| Return on Equity | 357.49% |
|---|---|
| Return on Assets | -189.17% |
| Return on Invested Capital | -547.08% |
Valuation & Multiples
| P/E Ratio | -2.1 |
|---|---|
| PEG | -2.34 |
| Price to Sales | - |
| Price to Book Ratio | -0.29 |
| Enterprise Value to Revenue | 47.28 |
| Enterprise Value to EBIT | -1.75 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | -2.47 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 24, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$63,000
Average shareholder expectationNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$53,694
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Amoéba S.A.
23 employees
CEO: Jean-Francois Doucet Amoéba S.A. focuses on the development and commercialization of anti-microbial and anti-fungal products. The company's primary innovation centers on harnessing the unique properties of the Willaertia magna C2c Maky amoeba, which it is ap...